Japan · Biotechnology startup
Japan · CellAxia
CellAxia is a biotechnology startup that creates medications for cell treatment.
Funding reportedLast round: Series B
What company datasets say CellAxia raised
Funding, as reported
Reported in all720Min the source's currency
Rounds3
Last roundSeries B
Last round dateSept 2020
Investors listed7
On a portfolio page
Investors who name them
Each firm lists CellAxia on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Japan
Startups like it
Is this your company?
Add your raise, your deck and your story, and put CellAxia in front of investors. Or tell us what we have wrong.